Zeda (previously PrinterPrezz / Vertex Manufacturing) is a global leader in advanced 3D manufacturing and nanotech solutions for the medical, space, aerospace, and defense industries.

Zeda's mission is to bring more ideas for innovative medical devices to market faster, connecting medicine and manufacturing to become the first Medifacturing™ company in the world.

Zeda was founded in 2018 by Shrinivas Shetty, Kishore Karkera and Alexis Dang. The company is headquartered in Fremont, California. Zeda now has 140,000 sq-ft across multiple advanced facilities in Silicon Valley, California, New Jersey, Ohio, and Singapore.

Zeda provides customers with access to a variety of 3D printing machines, 3D manipulation software, and 3D scanners as well as advanced manufacturing processes, and surgeon education programs.

Zeda combines robust additive manufacturing technology platforms, nanotechnologies and surgical expertise to develop next generation medical devices from concept and design through FDA approval and volume production.

Zeda's open design and manufacturing ecosystem reduces engineering iterations by optimizing medical devices designs and reducing time-to-market. In 2022, Zeda announced an agreement with the Singapore Healthcare Clusters and the National Additive Manufacturing Innovation Cluster (NAMIC) to grow the 3D-printed implant market in the region.

Zeda is backed by Boutique Venture Partners, Berkeley Catalyst Fund, DOV Management, Taiyo Nippon Sanso Corporation, Fives Group, Solvay Ventures, Michelin, and others. The company closed a $52M Series B including an equity and debt financing on Mar 07, 2023. This brings Zeda's total funding to $68M to date.